Vildagliptin (100mg) """

Vildagliptin (100mg)
VILDIABATE is an oral medication that belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. VILDIABATE is primarily used for the management of type 2 diabetes mellitus. Type 2 diabetes is a chronic condition characterized by insulin resistance and impaired insulin secretion, leading to elevated blood sugar levels.
VILDIABATE works by inhibiting the activity of the DPP-4 enzyme. This enzyme is responsible for breaking down incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones play a role in regulating blood sugar levels by increasing insulin secretion and decreasing glucagon release from the pancreas after meals.
By inhibiting DPP-4, VILDIABATE prolongs the action of GLP-1 and GIP, which in turn enhances insulin secretion in response to elevated blood sugar levels. This helps to reduce post-meal glucose spikes and helps control overall blood sugar levels in individuals with type 2 diabetes.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/vildiabate-100-133452